Gene Mutations in the Succinate Dehydrogenase Subunit SDHB Cause Susceptibility to Familial Pheochromocytoma and to Familial Paraganglioma
Open accessThe DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.
Abstract
The pheochromocytomas are an important cause of secondary hypertension. Although pheochromocytoma susceptibility may be associated with germline mutations in the tumor-suppressor genes VHL and NF1 and in the proto-oncogene RET, the genetic basis for most cases of nonsyndromic familial pheochromocytoma is unknown. Recently, pheochromocytoma susceptibility has been associated with germline SDHD mutations. Germline SDHD mutations were originally described in hereditary paraganglioma, a dominantly inherited disorder characterized by vascular tumors in the head and the neck, most frequently at the carotid bifurcation. The gene products of two components of succinate dehydrogenase, SDHC and SDHD, anchor the gene products of two other components, SDHA and SDHB, which form the catalytic core, to the inner-mitochondrial membrane. Although mutations in SDHC and in SDHD may cause hereditary paraganglioma, germline SDHA mutations are associated with juvenile encephalopathy, and the phenotypic consequences of SDHB mutations have not been defined. To investigate the genetic causes of pheochromocytoma, we analyzed SDHB and SDHC, in familial and in sporadic cases. Inactivating SDHB mutations were detected in two of the five kindreds with familial pheochromocytoma, two of the three kindreds with pheochromocytoma and paraganglioma susceptibility, and 1 of the 24 cases of sporadic pheochromocytoma. These findings extend the link between mitochondrial dysfunction and tumorigenesis and suggest that germline SDHB mutations are an important cause of pheochromocytoma susceptibility.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“germline mutations in the B, C and D subunits of SDH predispose individuals to hereditary paragangliomatosis with phaeochromocytomas (HPGL) (2 -6)”
From Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations (2005) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For instance, a biallelic loss of succinate dehydrogenase (SDH), an alteration found in familial paragangliomas and pheochromocytomas, as well as in a subset of sporadic gastrointestinal stromal tumors, creates a build-up of succinate (Astuti et al., 2001; Janeway et al., 2011).”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Astuti et al., 2001
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The results of a clinical study further confirmed this observation by showing that patients with nonmetastatic lung cancer harbored loss-of-function mutations in SDH5128.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [128]
Experimental — accuracy not yet measuredIn the citing paper
“In cancer cells, mutations in succinate dehydrogenase subunit B (SDHB) cause susceptibility to familial pheochromocytoma99 and familial paraganglioma100 as well as gastrointestinal stromal tumors101.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [99]
In the citing paper
“In addition to the tumorigenic effects of succinate accumulation, SDH5 mutation is the key driver supporting the acquisition of epithelial–mesenchymal transition (EMT) characteristics.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [128]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Green, D. R., & Reed, J. C. (1998) · Science · doi:10.1126/science.281.5381.1309 · Cited by 8,965
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180 · cited 2×
“…cancers and in mouse models, results in up-regulation of angiogenic growth factors, such as vascular endothelial growth factor, secondary to a defect in ubiquitylation of the a-subunits of the HIF-1 and the HIF-2 transcription factors (Maxwell et al. 1999; Cockman et al. 2000; Ohh et al. 2000).”
BackgroundSelf-citationMutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638 · cited 3×
“…the iron-sulfur–protein subunit) and in both SDHC and SDHD (i.e., the genes for the integral membrane–protein subunits) are associated with neoplasia (Baysal et al. 2000; Niemann and Muller 2000; present study), autosomal recessive homozygous SDHA (i.e., the gene for the flavoprotein subunit)…”
BackgroundOhh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T.-Y., Huang, L. E., Pavletich, N., Chau, V., & Kaelin, W. G. (2000) · Nature Cell Biology · doi:10.1038/35017054 · Cited by 1,577 · cited 2×
“…cancers and in mouse models, results in up-regulation of angiogenic growth factors, such as vascular endothelial growth factor, secondary to a defect in ubiquitylation of the a-subunits of the HIF-1 and the HIF-2 transcription factors (Maxwell et al. 1999; Cockman et al. 2000; Ohh et al. 2000).”
BackgroundCockman, M. E., Masson, N., Mole, D. R., Jaakkola, P., Chang, G.-W., Clifford, S. C., Maher, E. R., Pugh, C. W., Ratcliffe, P. J., & Maxwell, P. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002740200 · Cited by 1,050 · cited 1×
“…cancers and in mouse models, results in up-regulation of angiogenic growth factors, such as vascular endothelial growth factor, secondary to a defect in ubiquitylation of the a-subunits of the HIF-1 and the HIF-2 transcription factors (Maxwell et al. 1999; Cockman et al. 2000; Ohh et al. 2000).”
BackgroundSelf-citationMutations in SDHC cause autosomal dominant paraganglioma, type 3
Niemann, S., & Müller, U. (2000) · Nature Genetics · doi:10.1038/81551 · Cited by 875 · cited 4×
“…herein: PGL1 (MIM 168000), which results from SDHD mutations at 11q23; PGL2 (MIM 601650), which maps to 11q13, although the causative gene has not been identified (Mariman et al. 1995); and PGL3 (MIM 605373), which results from SDHC mutations at 1q21 (Baysal et al. 2000; Niemann and Muller 2000).”
BackgroundInfluentialBourgeron, T., Rustin, P., Chretien, D., Birch-Machin, M., Bourgeois, M., Viegas-Péquignot, E., Munnich, A., & Rötig, A. (1995) · Nature Genetics · doi:10.1038/ng1095-144 · Cited by 730 · cited 2×
“SDHA mutations are associated with juvenile encephalopathy (Bourgeron et al. 1995), and the phenotypic consequences of SDHB mutations have not been defined.”
BackgroundHoffman, M. A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.10.1019 · Cited by 382 · cited 1×
“Interestingly, germline VHL mutations that predispose patients to pheochromocytoma do not impair HIF-1a ubiquitylation (Clifford et al. 2001; Hoffman et al. 2001).”
BackgroundClifford, S. C. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.10.1029 · Cited by 373
Gimm, O., Armanios, M. Y., Dziema, H., Neumann, H. P. H., & Eng, C. (2000) · PubMed · Cited by 274
Self-citation
Cited by
Items 801–900 of 999
Genetic profile of Indian pheochromocytoma and paraganglioma patients – A single institutional study
Agarwal, G., Rajan, S., Valiveru, R. C., Tulsyan, S., Agrawal, V., Mittal, B., Zaidi, G., Mayilvaganan, S., Mishra, A., Agarwal, A., et al. (2019) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_163_19 · Cited by 5
Braun, M. M., Damjanac, T., Zhang, Y., Chen, C., Hu, J., & Maher, L. J., III (2019) · PLoS ONE · doi:10.1371/journal.pone.0227033 · Cited by 6
Pacák, K., Timmers, H. J. L. M., & Eisenhofer, G. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00110-4 · Cited by 5
Outcomes of Carotid Body Tumor Management with Active Surveillance
Lyle, D. A., Lopez, A., Osofsky, R. B., Wiemann, B. Z., Boyd, N. H., Olson, G. T., & Rana, M. A. (2022) · Annals of Otology Rhinology & Laryngology · doi:10.1177/00034894221105833 · Cited by 4
Sato, H., Kanai, G., Hirabayshi, K., Kajiwara, H., Itoh, J., & OSAMURA, R. Y. (2010) · Endocrine · doi:10.1007/s12020-010-9365-x · Cited by 5
Kunkle, B. W., Felty, Q. H., Narasimhan, G., Treviño, F., & Roy, D. (2009) · Cited by 5
Multiple Endocrine Neoplasia Syndrome
Kakudo, K., Ito, Y., & Takahashi, M. (2009) · Springer eBooks · doi:10.1007/978-1-4419-1069-1_24 · Cited by 4
Genetic Syndromes Associated with Adrenal Tumors
Åkerström, G., & Hellman, P. (2005) · Springer eBooks · doi:10.1007/3-540-26861-8_25 · Cited by 7
Pheochromocytoma and the Multiple Endocrine Neoplasia Syndromes
Chernausek, S. D., & Eng, C. (2008) · Elsevier eBooks · doi:10.1016/b978-141604090-3.50018-1 · Cited by 5
Self-citationPheochromocytoma and multiple endocrine neoplasia syndromes
Waguespack, S. G., & Ying, A. K. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00023-8 · Cited by 8
Barbolosi, D., Crona, J., Serre, R., Pacák, K., & Taïeb, D. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201303 · Cited by 7
13 C Flux Analysis in Biotechnology and Medicine
Cheah, Y. E., Hasenour, C. M., & Young, J. D. (2017) · Wiley eBooks · doi:10.1002/9783527696130.ch2 · Cited by 8
Special Issue: Cancer Metabolism
Madhu, B. (2017) · Metabolites · doi:10.3390/metabo7030041 · Cited by 5
“The recent interesting findings on glycolysis, glutaminolysis, serine/glycine metabolism, amino acid metabolism, lipid and membrane lipid metabolism, and TCA cycle enzyme (SDH, FH and IDH) mutations in cancer cells led to a renewed interest in the field of cancer metabolism.”
BackgroundInfluentialSilva, L. F. O., Skiados, N. G., Murugavel, N., Cover, K., Luna, N., Gupta, M., Contreras, S. C., O’Brien, T. E., & Zhang, W. C. (2025) · Cancer Cell International · doi:10.1186/s12935-025-04002-7 · Cited by 7
“Loss-of-function mutations in SDHB , SDHC , and SDHD correlate with hereditary paraganglioma and pheochromocytoma, renal carcinoma, and gastrointestinal stromal tumor [6–8].”
Changes in tumor and cardiac metabolism upon immune checkpoint
Leven, A., Wagner, N., Nienaber, S., Messiha, D., Tasdogan, A., & Ugurel, S. (2024) · Basic Research in Cardiology · doi:10.1007/s00395-024-01092-8 · Cited by 8
Rare vertebral metastasis in a case of Hereditary Paraganglioma
da Silva, M. E. R., Carvalho, M. J. Q. D. F. S., Rodrigues, A. P. C., Nevès, N., Gonçalves, A. M., Pinto, R. A. P., & Carvalho, D. M. (2012) · Hereditary Cancer in Clinical Practice · doi:10.1186/1897-4287-10-12 · Cited by 4
“Several studies have suggested that patients who are carriers of the SDHB mutation [PGL type 4], like the patient we describe, are more likely to develop extra-adrenal lesions [abdominal or thoracic] and malignant disease [10].”
BackgroundDiagnostic Investigation of Lesions Associated with Succinate Dehydrogenase Defects
Taïeb, D., Timmers, H. J. L. M., & Pacák, K. (2018) · Hormone and Metabolic Research · doi:10.1055/a-0586-3710 · Cited by 5
One genotype, many phenotypes: SDHB p.R90X mutation-associated paragangliomas
Alzahrani, A. S., Alswailem, M. M., Moria, Y., Aldeheshi, A., & Al‐Hindi, H. (2020) · Endocrine · doi:10.1007/s12020-020-02461-8 · Cited by 4
Chaurasia, A., Turkbey, E. B., Firouzabadi, F. D., Singh, S. M., Samimi, S., Gopal, N., Millo, C., Ball, M. W., Linehan, W. M., & Malayeri, A. A. (2024) · Clinical Imaging · doi:10.1016/j.clinimag.2024.110280 · Cited by 4
Ishii, T., Yasuda, K., Miyazawa, M., Onouchi, H., Yanase, S., & Ishii, N. (2025) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.25-62 · Cited by 5
An autopsy case of bilateral adrenal pheochromocytoma-associated cerebral hemorrhage
Mizukami, H., Hara, S., Kobayashi, M., Mori, S., Kuriiwa, F., & Fukunaga, T. (2012) · Legal Medicine · doi:10.1016/j.legalmed.2012.08.007 · Cited by 4
Molecular Imaging in Hereditary Succinate Dehydrogenase Mutation–Related Paragangliomas
Marzola, M. C., & Rubello, D. (2014) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000000572 · Cited by 4
Avoiding and Nonexpressing: Coping Styles of Patients With Paragangliomas
van Hulsteijn, L. T., Kaptein, A. A., Louisse, A., Smit, J. W. A., & Corssmit, E. P. M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1340 · Cited by 5
Clinical Challenges in Nonfunctional Pheochromocytomas
Parameswaran, R., Lui, S., Oh, H. B., & Tan, K. B. (2019) · World Journal of Endocrine Surgery · doi:10.5005/jp-journals-10002-1264 · Cited by 4
Metabolism and secretion mechanism of catecholamine syndrome and related treatment strategies
Liu, Y., Wang, Y., Zhou, M., Zhang, L., Pang, Y., Wang, C., Xiao, Q., & Liu, L. (2020) · Journal of Xiangya Medicine · doi:10.21037/jxym-20-88 · Cited by 5
“In addition, GDNF, GNAS, H-ras, K-ras, CDKN2A (p16), p53, BRCA1&2, BAP1, ATRX and KMT2D mutations also play roles in the development of pheochromocytoma (16-27).”
BackgroundMitophagy and Reverse Warburg Effect: Metabolic Compartmentalization of Tumor Microenvironment
Naik, P. P. (2020) · Springer eBooks · doi:10.1007/978-981-15-6930-2_6 · Cited by 5
Jia, L., Deng, F.-M., Kong, M. X., Wu, C., & Yang, X. J. (2021) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2021-0107-ra · Cited by 4
Higashi, S., Sasaki, T., Uchida, K., Kageyama, T., Ikejiri, M., Matsumoto, R., Kato, M., Masui, S., Yoshio, Y., Nishikawa, K., et al. (2022) · Human Genome Variation · doi:10.1038/s41439-022-00202-z · Cited by 4
Carotid paragangliomas. Alternatives for presurgical endovascular management
Gaviria, A. M. R., Ovaez, E. E. N., Rodea, C. A. S., & Sanchez, A. F. S. (2022) · Radiology Case Reports · doi:10.1016/j.radcr.2022.07.010 · Cited by 4
“[4] Astuti D, Latif F, Dallol A, Dahia PL, Douglas F, George E, et al.”
BackgroundÖrökletes vesetumor-szindrómák. Patológiai és genetikai áttekintés
Sánta, F., Semjén, D., & Kuthi, L. (2023) · Orvosi Hetilap · doi:10.1556/650.2023.32729 · Cited by 8
Mechanisms of Bioenergy Production in Mitochondria
Marín-García, J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4599-9_5 · Cited by 4
The Genetic Basis of Kidney Cancer and Implications for Targeted Therapies
Schmidt, L. S., Srinivasan, R., & Linehan, W. M. (2012) · Springer eBooks · doi:10.1007/978-1-4614-2400-0_1 · Cited by 4
Cardiac paraganglioma with a novel germline mutation of succinate dehydrogenase gene D
Otani, N., Sugano, K., Inami, S., Amano, H., Arikawa, T., Saito, S., Imai, K., Ushiama, M., Yoshida, T., Kimura, N., et al. (2017) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyx132 · Cited by 4
“SDHC and SDHD anchor two additional subunits, SDHA and SDHB, to the inner-mitochondrial membrane (5).”
BackgroundSDHC Methylation Pattern in Patients With Carney Triad
Daumová, M., Švajdler, M., Fabián, P., Křen, L., Babankova, I., Ježová, M., Šedivcová, M., Vaněček, T., Behenska, K., Michal, M., et al. (2021) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000920 · Cited by 4
Hereditary Neuroendocrine Tumor Syndromes
Faggiano, A., Ramundo, V., Circelli, L., & Colao, A. (2013) · InTech eBooks · doi:10.5772/53841 · Cited by 3
“Shortly after, germline mutations were also identified in SDHB in both PCCs and PGLs [80].”
BackgroundInfluentialPheochromocytoma and Paraganglioma
Meyer-Rochow, G. Y., & Sidhu, S. B. (2009) · Cancer treatment and research · doi:10.1007/978-1-4419-0857-5_9 · Cited by 5
SDHD-Related Chromaffin Tumours: Disease Localisation to Genetic Dysfunction
Srirangalingam, U., Khoo, B. C. E., Matson, M. B., Carpenter, R., Reznek, R. H., Maher, E. R., Chew, S. L., & Drake, W. M. (2010) · Hormone Research in Paediatrics · doi:10.1159/000277659 · Cited by 5
Self-citationAlzahrani, A. S., Alshaikh, O. M., Faiyaz‐Ul‐Haque, M., Halah, B., Al‐Dayel, F., & Al‐Hindi, H. (2010) · Endocrine Practice · doi:10.4158/ep09315.cr · Cited by 4
Paraganglioma carotídeo familiar
Martínez-Aguilar, E., March-García, J. R., Haro, J. D., Flórez-González, A., Varela, C., & Acín, F. (2008) · Angiología · doi:10.1016/s0003-3170(08)02007-5 · Cited by 4
“Actualmente, se han identificado cuatro loci res-ponsables: tres de ellos codifican subunidades del complejo II mitocondrial, SDHB (PGL4) [15], SDHC (PGL3) [16] y SDHD (PGL1) [17].”
Accordi, E. D., Xekouki, P., Azevedo, B., de Alexandre, R. B., Frasson, C., Gantzel, S. M., Papadakis, G. Z., Angelousi, A. G., Stratakis, C. A., Sotomaior, V. S., et al. (2016) · European Thyroid Journal · doi:10.1159/000444522 · Cited by 3
ARHI is a novel epigenetic silenced tumor suppressor in sporadic pheochromocytoma
Wang, D., Li, S., Wang, L., Zhao, L., Xiang, B., Li, Y., Shan, B., & Liu, J. (2017) · Oncotarget · doi:10.18632/oncotarget.21149 · Cited by 4
Role of Succinate Dehydrogenase in Cellular Respiration
Viswalingam, V., & Kumar, D. (2025) · Springer eBooks · doi:10.1007/978-981-96-6831-1_3 · Cited by 3
Gao, Y., Xiong, Z., & Wei, X. (2025) · Metabolites · doi:10.3390/metabo15080513 · Cited by 6
“The defects or mutations of SDH have been disclosed in an extensive range of human tumors, including paraganglioma, pheochromocytoma, gastrointestinal stromal tumors, renal cell cancer (RCC), thyroid tumors, seminomatous testicular cancer, and neuroblastic tumors [165–171].”
Cubiella, T., Alba‐Linares, J. J., San‐Juan‐Guardado, J., Suárez‐Priede, Á., Gomez-Suarez, N., Tous, M. D. C., Bancos, I., Villabona, C. M., Piñol, T. S., Tena, I., et al. (2026) · Communications Biology · doi:10.1038/s42003-026-09543-9 · Cited by 4
“Genetic alterations play a crucial role in PPGL pathogenesis, particu-larlymutationsaffectingthesuccinatedehydrogenase(SDH)complex 2 – 5 .”
Genetic-clinical profile of subjects with apparently sporadic extra-adrenal paragangliomas
Ramundo, V., Ercolino, T., Faggiano, A., Giachè, V., Ragghianti, B., Rapizzi, E., Colao, A., & Mannelli, M. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00065 · Cited by 3
“…the structural (SDHD, SDHC) and catalytic (SDHB) succinate dehydrogenase subunits predispose to hereditary paraganglioma syndromes named PGL-1 (OMIM #168000), PGL-3 (OMIM #605373), and PGL-4 (OMIM #115310), respectively (Baysal et al., 2000; Astuti et al., 2001, 2003; Neumann et al., 2002).”
BackgroundMetabolic basis of cardiac dysfunction in cancer patients
Figueiredo, J. C., Bhowmick, N. A., & Karlstaedt, A. (2024) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000001118 · Cited by 3
Ragab, E. M., Khamis, A. A., Gamal, D. M. E., & Mohamed, T. M. (2024) · Genes & Nutrition · doi:10.1186/s12263-024-00740-x · Cited by 3
“1, consists of 8 exons [2, 80].”
Delaney, F. T., Chung, R., Blake, M. A., & Sweeney, A. T. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.05.743 · Cited by 5
Hatzi, V. I., Terzoudi, G. I., Pantelias, G. E., & Makropoulos, V. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.10.002 · Cited by 3
Diagnosis and management of hereditary paraganglioma syndrome due to the F933>X67 SDHD mutation
Marvin, M. L., Bradford, C. R., Sisson, J. C., & Gruber, S. B. (2008) · Head & Neck · doi:10.1002/hed.20930 · Cited by 3
Treatment for Paragangliomas: Passing the Test of Time
Ngwenya, L. B., & Chiocca, E. A. (2012) · World Neurosurgery · doi:10.1016/j.wneu.2011.05.001 · Cited by 3
Undiagnosed Pheochromocytoma Simulating Malignant Hyperthermia
Ramani, N. S., Stoppacher, R., Morani, A. C., & CATANESE, C. A. (2017) · American Journal of Forensic Medicine & Pathology · doi:10.1097/paf.0000000000000326 · Cited by 3
Sarkadi, B., Grolmusz, V. K., Butz, H., Kövesdi, A., Likó, I., Nyírő, G., Igaz, P., & Patócs, A. (2018) · Orvosi Hetilap · doi:10.1556/650.2018.31036 · Cited by 5
“Az újabban felfedezett gének szisztematikus vizsgálatát elvégezve 82 sporadikusnak vélt Phaeo/PGL betegben 11 esetben igazoltunk patogén eltérést, amelyek közül 4 SDHB és 2 TMEM127 mutáció új mutáció volt.”
InfluentialHemminki, A., & Hemminki, K. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-785-7_2 · Cited by 3
Pacák, K., Timmers, H. J. L. M., & Eisenhofer, G. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00109-x · Cited by 8
Shi, C., Liu, J., Zeng, Z.-P., Miao, Q., Fang, L., Chen, S., Ping, F., Sun, H., Lü, L., Chen, L., et al. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad093 · Cited by 4
Mitochondria and Mitochondrial Disorders
Morava, É., & Smeitink, J. A. M. (2005) · Springer eBooks · doi:10.1007/3-540-27660-2_23 · Cited by 3
Fernández‐Pombo, A., Cameselle‐Teijeiro, J., Puñal-Rodríguez, J. A., Loidi, L., Peinó-García, R., Cabanas, P., Pumar, M. G., Baleato‐González, S., Flores, E., & Araújo‐Vilar, D. (2019) · Case Reports in Endocrinology · doi:10.1155/2019/2502174 · Cited by 3
“However, 20–30% of all cases are part of well characterized hereditary tumour syndromes [2], such as von Hippel-Lindau disease, Multiple Endocrine Neoplasia type 2 and Neurobromatosis type 1, which occur as a result of germline variants in VHL, RET, NF1, and SDH (subunits A, B, C, D and AF2) genes [3].”
BackgroundSomatic SDHA mutations in paragangliomas in siblings: Case report of 2 cases
Huang, Y.-C., Chang, H., Chen, M., Huang, K., Li, A. F., Lin, C., Shyr, Y., & Fang, W. (2020) · Medicine · doi:10.1097/md.0000000000022497 · Cited by 4
Disorders of the Venous System
Brouillard, P., Limaye, N., Boon, L. M., & Vikkula, M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00179-8 · Cited by 3
Mitochondria-Mediated Oxidative Stress and Cancer Therapy
Ahmad, I. M., & Abdalla, M. Y. (2011) · Humana Press eBooks · doi:10.1007/978-1-61779-397-4_1 · Cited by 3
Patogênese molecular do feocromocitoma
Dahia, P. L. M. (2001) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302001000600003 · Cited by 4
Self-citation‘Cerebral vasculitis’: Mistaken cause of fluctuating blood pressure and neurological manifestations
Manger, W. M. (2007) · Kidney International · doi:10.1038/sj.ki.5002590 · Cited by 3
Carotid Body Tumors and Adrenal Pheochromocytomas in Siblings of a Turkish Family
Erem, C., Hacıhasanoğlu, A., Çinel, A., Işık, A. Ü., Reis, A., Sari, A., Ersöz, H. Ö., & Ükinç, K. (2006) · Medical Principles and Practice · doi:10.1159/000094277 · Cited by 3
“Pheochromocytomas (pheos) are catecholamine-producing, chromaffin tumors that arise in the adrenal medulla in 90p of cases and extra-adrenal sympathetic ganglia in the remaining 10p [”
BackgroundSato, H., Shoji, S., Kajiwara, H., Itoh, J., & OSAMURA, R. Y. (2013) · Endocrine Pathology · doi:10.1007/s12022-013-9252-0 · Cited by 3
Association of mitochondrial disorders with lymphoid malignancies
Mende, S., Koch, R., Schmiedel, J., Reichmann, H., & Storch, A. (2007) · Mitochondrion · doi:10.1016/j.mito.2007.08.003 · Cited by 3
Persu, A., Amyere, M., Gutierrez-Roelens, I., Rustin, P., Sempoux, C. L., Lecouvet, F. E., BEERS, B. E. V., Horsmans, Y., Plaen, J.-F. D., MarcHamoir, et al. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e328317a777 · Cited by 3
15. Management of Paraganglioma
Neumann, H. P. H., & Eng, C. (2010) · The Endocrine Society eBooks · doi:10.1210/caem1.9781936704606.ch15 · Cited by 4
Self-citationA mutation of the succinate dehydrogenase B gene in a Korean family with paraganglioma
Sagong, B., Seo, Y. J., Lee, H., Kim, M., Kim, U., & Moon, I. S. (2016) · Familial Cancer · doi:10.1007/s10689-016-9874-8 · Cited by 3
Hereditary Renal Cell Carcinoma
Baba, M., Schmidt, L. S., & Linehan, W. M. (2017) · Springer eBooks · doi:10.1007/978-4-431-55531-5_2 · Cited by 4
Neuroendocrine Tumors: Therapy with 131I-MIBG
Carrasquillo, J. A., & Chen, C. C. (2016) · Springer eBooks · doi:10.1007/978-3-319-26067-9_26-1 · Cited by 3
de Vos, B., Rijken, J. A., Adank, M. A., Hoksbergen, A. W. J., Bayley, J., Leemans, C. R., & Hensen, E. F. (2018) · Clinical Otolaryngology · doi:10.1111/coa.13059 · Cited by 3
“The majority of HNPGL, extra-adrenal PGL and PHEO are caused by germline variants in genes encoding subunits and cofactors of the succinate dehydrogenase (SDH) enzyme complex (A, B, C, D, AF2).5-7 The associated syndromes are quite distinct.”
BackgroundChen, W. M., Olson, P., Arcot, R., Nguyen, H. Q., Qureshi, F., Kokenakes, C., & Cher, M. L. (2021) · Journal of Kidney Cancer and VHL · doi:10.15586/jkcvhl.v8i1.129 · Cited by 3
Metabolic Reprogramming in Cancer
Prusty, D., & Manna, S. K. (2022) · Wiley eBooks · doi:10.1002/9781119851042.ch25 · Cited by 3
Semzenisi, E., Hodor, D., Sall, I. M., Toma, C. G., & Tăbăran, F. (2024) · Frontiers in Veterinary Science · doi:10.3389/fvets.2024.1409701 · Cited by 3
Consultation génétique des phéochromocytomes et paragangliomes
Cardot-Bauters, C., Ainaouï, M., Coppin, L., & Pigny, P. (2014) · La Presse Médicale · doi:10.1016/j.lpm.2013.07.032 · Cited by 3
Illness perceptions, risk perception and worry in SDH mutation carriers
van Hulsteijn, L. V., Kaptein, A., Louisse, A., Biermasz, N., Smit, J., & Corssmit, E. (2014) · Familial Cancer · doi:10.1007/s10689-013-9680-5 · Cited by 6
“Germline mutations in subunits B and D of the succinate dehydrogenase (SDH) gene are significant causes of inherited paragangliomas (PGLs); neuroendocrine tumors of the paraganglia [1, 2].”
BackgroundLan, L., Liu, P., Tian, Y., Zhu, B., Shen, L., & Huang, Y. (2020) · BMC Anesthesiology · doi:10.1186/s12871-020-00998-9 · Cited by 2
Role of succinate dehydrogenase in hepatocellular carcinoma
Srivani, G., Imran, M., Merchant, N., Mandala, J. P., & Nagaraju, G. P. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-98806-3.00014-3 · Cited by 2
Modern conceptions on neck paragangliomas
Chupin, A. V., Verdikhanov, N. I., & Golovyuk, A. L. (2022) · Pirogov Russian Journal of Surgery · doi:10.17116/hirurgia202207164 · Cited by 2
A big picture of the mitochondria-mediated signals: From mitochondria to organism
Acar, N. V., & Özgül, R. K. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.08.032 · Cited by 2
Chang, E. S., Song, K., Song, J.-Y., Sung, M., Lee, M., Oh, J. H., Kim, J., Park, Y. H., Jung, K., & Choi, Y. (2024) · Cancer & Metabolism · doi:10.1186/s40170-024-00353-3 · Cited by 4
“Complications in complex II can also lead to cancer, cell death, and necrosis [24, 25].”
BackgroundGaspar, L. M., Gonçalves, C. I., Nobre, E. L., Fonseca, F., Amaral, C., Duarte, J. S., Raimundo, L., Saraiva, C., Cortez, L., Marques, O., et al. (2025) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2025.100389 · Cited by 2
“The SDHB gene is associated with paragangliomas and pheochro-mocytomas [38].”
Mitochondrial Respiratory Chain Complex II
Ganesh, J., Wong, L. C., & Gorman, E. B. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3722-2_13 · Cited by 4
Paragangliomas of the Head and Neck
van Nes, J. G. H., de Jong, S. C., van Sambeek, M. R. H. M., & van Urk, H. (2006) · Springer eBooks · doi:10.1007/1-84628-211-x_31 · Cited by 2
Extraadrenal pheochromocytoma associated to SDHD gene mutation
Lendvai, N., Szabó, I., Butz, H., Bekő, G., Horányi, J., Tarjányi, M., Alföldi, S., Szabó, I., Rácz, K., & Patócs, A. (2009) · Orvosi Hetilap · doi:10.1556/oh.2009.28587 · Cited by 3
Huang, D., HUANG, L., Tian, J., SUN, A., & Xu, F. (2014) · Oncology Letters · doi:10.3892/ol.2014.2432 · Cited by 2
“Using candidate gene analysis, subsequent studies confirmed the correlation of SDH subunit B (5) and C (6) germline mutations with the occurrence of hereditary paragangliomas, however, not with that of sporadic paragangliomas (7).”
Graham, D., Gooch, M., Ye, Z., Richer, E. J., Chishti, A. S., Reilly, E. A., & D'Orazio, J. A. (2014) · Case Reports in Genetics · doi:10.1155/2014/273423 · Cited by 2
“More recently, genes that encode proteins in the mitochondrial complex II, particularly the succinyl dehydrogenase components SDHD, SDHB, and SDHC, have been identified as causative for PCC-PGL syndromes [1, 23–27].”
Genetic Diagnosis of Pheochromocytoma
Takekoshi, K., Isobe, K., & Kawakami, Y. (2008) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.97.2558 · Cited by 2
The Electron Transport Chain and Carcinogenesis
Brière, J.-J., Bénit, P., & Rustin, P. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-435-3_2 · Cited by 3
“The use of a candidate gene approach has led to the identification of mutations in SDHC (PGL3) and SDHB (PGL4) [24, 25].”
BackgroundApports de COMETE à la génétique du phéochromocytome
Gimenez‐Roqueplo, A., Burnichon, N., Amar, L., Favier, J., Jeunemaître, X., & Plouin, P. (2008) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)32851-1 · Cited by 4
Malignant pheochromocytoma in the elderly: which is the best management in clinical practice?
Mazza, A., & Rubello, D. (2015) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000000386 · Cited by 3
Secondary Hypertension: Pheochromocytoma
Young, W. F. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-3053-9.50016-0 · Cited by 3
Unusual cardiac paraganglioma mimicking an atypical carcinoid tumor of the lung
Spencer, D., Evans, M. G., Wang, B., Delrosario, J. L., Cheng, T., & Milliken, J. C. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2017.11.132 · Cited by 2
“Therefore, genetic testing is recommended in patients with cardiac PG (8).”
BackgroundWeiss, L. M., & Lau, S. K. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3966-2.00045-x · Cited by 3
Paraganglioma and Pheochromocytoma
Iacobone, M., & Torresan, F. (2021) · Springer eBooks · doi:10.1007/978-3-030-62241-1_15 · Cited by 2
Neuroendocrine Tumors: Therapy with 131I-MIBG
Carrasquillo, J. A., & Chen, C. C. (2017) · Springer eBooks · doi:10.1007/978-3-319-26236-9_26 · Cited by 2
Effect of Pd(II) and Ni(II) coordination compounds with 4-amino-3-mercapto-5-methyl-1,2,4-triazole
Orysyk, S. I. (2015) · The Ukrainian Biochemical Journal · doi:10.15407/ubj87.01.064 · Cited by 2
Genetics and Tumor Microenvironment of Renal Cell Carcinoma
Khaleel, S. S., Ricketts, C. J., Linehan, W. M., Ball, M. W., Manley, B. J., Turajlic, S., Brugarolas, J., & Hakimi, A. A. (2022) · Société Internationale d’Urologie Journal · doi:10.48083/blpv3411 · Cited by 3
Molecular Biology of Pheochromocytomas and Paragangliomas
King, E. E., & Dahia, P. L. M. (2009) · Springer eBooks · doi:10.1007/978-1-4419-1069-1_13 · Cited by 2
Self-citation
Metadata
- Authors
- Astuti, D., Latif, F., Dallol, A., Dahia, P. L. M., Douglas, F., George, E., Sköldberg, F., Husebye, E. S., Eng, C., & Maher, E. R.
- Affiliations
- University of Birmingham (GB)
- Dana-Farber Cancer Institute (US)
- Royal Victoria Infirmary (GB)
- Queen Elizabeth Hospital (GB)
- Uppsala University (SE)
- University of Cambridge (GB)
- Corresponding author
- Maher, Eamonn R.
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2001-07
- Volume
- 69
- Issue
- 1
- Pages
- 49-54
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC1226047
- OpenAlex
- W2025719835
- Cited by
- 1,087
- References
- 28
- Citations by year
- 2026: 16 · 2025: 18 · 2024: 18 · 2023: 31 · 2022: 29 · 2021: 40 · 2020: 29 · 2019: 51 · 2018: 42 · 2017: 47 · 2016: 54 · 2015: 46 · 2014: 70 · 2013: 61 · 2012: 75
- FWCI
- 37.27
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 4401 d)
- Locations
- The American Journal of Human Genetics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- British Heart Foundation
- National Cancer Institute (P-30-CA-16058, P30CA016058)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Clinical Neurology › Neurofibromatosis and Schwannoma Cases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- succinate dehydrogenase, SDHB, SDHC, pheochromocytoma, paraganglioma, germline mutations, mitochondrial dysfunction, sporadic pheochromocytoma, tumor suppressor, RET proto-oncogene, VHL, neurofibromatosis type 1
- MeSH terms
- Proto-Oncogene Mas, Amino Acid Sequence, Base Sequence, DNA Mutational Analysis, Female, Haplotypes, Humans, Male, Molecular Sequence Data, Mutation, Paraganglioma, Pedigree, Pheochromocytoma, Succinate Dehydrogenase, Sequence Alignment, Germ-Line Mutation, Loss of Heterozygosity, Genetic Predisposition to Disease, Mutation, Missense, Protein Subunits
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.